Clinical trial
Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic…
NCT00231998 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00231998 |
|---|---|
| Title | Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis |
| Official title | A Clinical Study Continued From the Confirmatory Study to Validate the Efficacy and Safety of Pimecrolimus Cream in Pediatric Atopic Dermatitis Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus |
| Enrollment | 240 |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 17, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: